generic ciclosporin preparations have been marketed under various trade names, including cicloral (sandoz/hexal), gengraf (abbott) and deximune (dexcel pharma). since 2002, a topical emulsion of ciclosporin for treating inflammation caused by keratoconjunctivitis sicca (dry eye syndrome) has been marketed under the trade name restasis (0.05%). ikervis is a similar formulation with a concentration of 0.1%. inhaled ciclosporin formulations are in clinical development, and include a solution in propylene glycol and liposome dispersions.